VICTORIA, British Columbia–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) (TSX:AUP) (“Aurinia” or the “Company”), a late-stage clinical biopharmaceutical company focused on advancing voclosporin in multiple indications, today announced that it has… Read More
Eric brings over 30 years of experience in the development of biopharmaceuticals, cell therapies, and regenerative medicine products VANCOUVER, BC — Aspect Biosystems, a biotechnology platform company pioneering the microfluidic… Read More
– FDA grants Priority Review and sets PDUFA date of January 22, 2021 – VICTORIA, British Columbia & ROCKVILLE, Md.–(BUSINESS WIRE)– Aurinia Pharmaceuticals Inc. (Nasdaq:AUPH / TSX:AUP) (“Aurinia” or the… Read More
Conference Call to be held Thursday, July 23, 2020 at 4:30pm ET SAN DIEGO, July 17, 2020 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) (“DelMar” or the “Company”), a biopharmaceutical company focused… Read More
The next-generation sutureless surgical technology is based on a clinically proven platform and designed for valve durability LONDON–(BUSINESS WIRE)–Jul. 16, 2020– LivaNova PLC (NASDAQ:LIVN) a market-leading medical technology and innovation company, today… Read More
